Preservation of the antioxidant status in chemically-induced diabetes mellitus by melatonin

Journal of Pineal Research

Volumn 29, Issue 2, 2000, Pages 108-115

  Sailaja Devi, M M ^a   Suresh, Y ^a   Das, U N ^b  

^a L V PRASAD EYE INSTITUTE   (India)

^b EFA Sciences Inc   (United States)

Author keywords

Atherosclerosis; Diabetes mellitus; Melatonin; Oxidant stress; Superoxide dismutase

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALLOXAN; GLUTATHIONE PEROXIDASE; MELATONIN; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; ENDOTHELIUM LESION; ENZYME ACTIVITY; GLYCATION; HYPERGLYCEMIA; LIPID PEROXIDATION; MALE; MICROVASCULATURE; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 0033856975     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079X.2000.290207.x     Document Type: Article

References (40)

1. Neurohormone melatonin prevents cell damage: Effect on gene expression for antioxidant enzymes
2. Melatonin stimulates brain glutathione peroxidase activity
3. The reaction between thiobarbituric acid and the oxidation products of certain lipids
4. Advanced glycation end products in tissue and the biochemical basis of diabetic complications
5. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products
6. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus, and coronary heart disease
7. Melatonin in health and disease
8. Beneficial effect Of L-arginine in non-insulin dependent diabetes mellitus: A potential role for nitric oxide
9. Lipid peroxides and essential fatty acids in patients with diabetes mellitus and diabetic nephropathy
10. Antioxidants and atherosclerotic heart disease
11. Analysis of nitrate, nitrite and N15 nitrite in biological fluids
12. Diabetes and cardiovascular disease: The Framingham study
13. Melatonin inhibits oxidative modification of human low density lipoprotein
14. Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation
15. Effect of melatonin on cis-platinum induced genetic damage to the bone marrow cells of mice
16. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex
17. Oxidant stress, antioxidants and nitric oxide in non-insulin dependent diabetes mellitus
18. Oxidant stress, antioxidants and essential fatty acids in systemic lupus erythematosus
19. Oxidant stress, antioxidants, nitric oxide and essential fatty acids in bronchial asthma
20. Effect of L-arginine-nitric oxide system in chemical induced diabetes mellitus
21. Catractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine. Preventive actions of melatonin
22. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women
23. Superoxide dismutase: An enzyme function for erythrocuprien (hemocuprien)
24. Oxidative stress in diabetic rats induced by streptozotocin: Protective effects of melatonin
25. The Ying and Yang of oxidation in the development of fatty streak: A review based on the 1994 George Nyman Duff Memorial Lecture
26. Cloning and expression of RAGE: A cell surface receptor for advanced glycosylation end products of proteins
27. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks
28. Time course of melatonin-induced increase in glutathione peroxidase activity in chick tissues
29. Antioxidant activity of melatonin in mice
30. Oxygen radical detoxification processes during aging: The functional importance of melatonin
31. Melatonin as a free radical scavenger. Implications for ageing and age-related diseases
32. Glucose and diabetic vascular diseases
33. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface
34. Melatonin: A potent endogenous hydroxyl radical scavenger
35. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: A biomarker of in vivo hydroxyl radical generation
36. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
37. Fiver year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin dependent diabetic and non-diabetic subjects
38. Are free radicals involved in the pathobiology of human essential hypertension?
39. Advanced glycation end products (AGEs) on the surface of diabetic red cells bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface associated AGEs and diabetic complications